Cargando…

Dose atrophy of vastus medialis obliquus and vastus lateralis exist in patients with patellofemoral pain syndrome

BACKGROUND: Whether vastus medialis obliquus atrophy exists in patients with patellofemoral pain syndrome and whether the amount of atrophy differs between the vastus medialis obliquus and vastus lateralis muscles remain unknown. MATERIALS: From June 2016 to March 2019, 61 patients with patellofemor...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Conglei, Li, Ming, Hao, Kuo, Zhao, Chao, Piao, Kang, Lin, Wei, Fan, Chongyi, Niu, Yingzhen, Fei, Wang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877190/
https://www.ncbi.nlm.nih.gov/pubmed/33568152
http://dx.doi.org/10.1186/s13018-021-02251-6
_version_ 1783650119012319232
author Dong, Conglei
Li, Ming
Hao, Kuo
Zhao, Chao
Piao, Kang
Lin, Wei
Fan, Chongyi
Niu, Yingzhen
Fei, Wang
author_facet Dong, Conglei
Li, Ming
Hao, Kuo
Zhao, Chao
Piao, Kang
Lin, Wei
Fan, Chongyi
Niu, Yingzhen
Fei, Wang
author_sort Dong, Conglei
collection PubMed
description BACKGROUND: Whether vastus medialis obliquus atrophy exists in patients with patellofemoral pain syndrome and whether the amount of atrophy differs between the vastus medialis obliquus and vastus lateralis muscles remain unknown. MATERIALS: From June 2016 to March 2019, 61 patients with patellofemoral pain syndrome were retrospectively included in the study group, and an age-, sex-, and body mass index-matched cohort of 61 patients with normal knees was randomly selected as the control group. All enrolled subjects had undergone CT scans in the supine position. The cross-sectional areas of the vastus medialis obliquus and the vastus lateralis muscle in the sections 0, 5, 10, 15, and 20 mm above the upper pole of the patella were measured, and the vastus medialis obliquus/vastus lateralis muscle area ratio was evaluated. RESULTS: In the study group, the vastus medialis obliquus areas and the vastus lateralis muscle areas in the sections that were 0, 5, 10, 15, and 20 mm above the upper pole of the patella were significantly smaller than the respective areas in the control group (P < 0.05). The vastus medialis obliquus/vastus lateralis muscle area ratio was significantly smaller at the upper pole of the patella (the section 0 mm above the upper pole of the patella) than the corresponding ratio in the control group (P < 0.05). No significant difference was noted between the two groups in the sections 5, 10, 15, and 20 mm above the upper pole of the patella (P > 0.05). CONCLUSION: In patients with patellofemoral pain syndrome, vastus medialis obliquus and vastus lateralis muscle atrophy existed in sections 0–20 mm above the upper pole of the patella, compared with normal controls, and atrophy of the vastus medialis obliquus was more evident than that of the vastus lateralis muscle at the upper pole of the patella. These findings support the rationale for the use of general quadriceps exercise combined with vastus medialis obliquus strengthening exercise as part of the rehabilitation programme for the patients with patellofemoral pain syndrome.
format Online
Article
Text
id pubmed-7877190
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78771902021-02-17 Dose atrophy of vastus medialis obliquus and vastus lateralis exist in patients with patellofemoral pain syndrome Dong, Conglei Li, Ming Hao, Kuo Zhao, Chao Piao, Kang Lin, Wei Fan, Chongyi Niu, Yingzhen Fei, Wang J Orthop Surg Res Research Article BACKGROUND: Whether vastus medialis obliquus atrophy exists in patients with patellofemoral pain syndrome and whether the amount of atrophy differs between the vastus medialis obliquus and vastus lateralis muscles remain unknown. MATERIALS: From June 2016 to March 2019, 61 patients with patellofemoral pain syndrome were retrospectively included in the study group, and an age-, sex-, and body mass index-matched cohort of 61 patients with normal knees was randomly selected as the control group. All enrolled subjects had undergone CT scans in the supine position. The cross-sectional areas of the vastus medialis obliquus and the vastus lateralis muscle in the sections 0, 5, 10, 15, and 20 mm above the upper pole of the patella were measured, and the vastus medialis obliquus/vastus lateralis muscle area ratio was evaluated. RESULTS: In the study group, the vastus medialis obliquus areas and the vastus lateralis muscle areas in the sections that were 0, 5, 10, 15, and 20 mm above the upper pole of the patella were significantly smaller than the respective areas in the control group (P < 0.05). The vastus medialis obliquus/vastus lateralis muscle area ratio was significantly smaller at the upper pole of the patella (the section 0 mm above the upper pole of the patella) than the corresponding ratio in the control group (P < 0.05). No significant difference was noted between the two groups in the sections 5, 10, 15, and 20 mm above the upper pole of the patella (P > 0.05). CONCLUSION: In patients with patellofemoral pain syndrome, vastus medialis obliquus and vastus lateralis muscle atrophy existed in sections 0–20 mm above the upper pole of the patella, compared with normal controls, and atrophy of the vastus medialis obliquus was more evident than that of the vastus lateralis muscle at the upper pole of the patella. These findings support the rationale for the use of general quadriceps exercise combined with vastus medialis obliquus strengthening exercise as part of the rehabilitation programme for the patients with patellofemoral pain syndrome. BioMed Central 2021-02-10 /pmc/articles/PMC7877190/ /pubmed/33568152 http://dx.doi.org/10.1186/s13018-021-02251-6 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Dong, Conglei
Li, Ming
Hao, Kuo
Zhao, Chao
Piao, Kang
Lin, Wei
Fan, Chongyi
Niu, Yingzhen
Fei, Wang
Dose atrophy of vastus medialis obliquus and vastus lateralis exist in patients with patellofemoral pain syndrome
title Dose atrophy of vastus medialis obliquus and vastus lateralis exist in patients with patellofemoral pain syndrome
title_full Dose atrophy of vastus medialis obliquus and vastus lateralis exist in patients with patellofemoral pain syndrome
title_fullStr Dose atrophy of vastus medialis obliquus and vastus lateralis exist in patients with patellofemoral pain syndrome
title_full_unstemmed Dose atrophy of vastus medialis obliquus and vastus lateralis exist in patients with patellofemoral pain syndrome
title_short Dose atrophy of vastus medialis obliquus and vastus lateralis exist in patients with patellofemoral pain syndrome
title_sort dose atrophy of vastus medialis obliquus and vastus lateralis exist in patients with patellofemoral pain syndrome
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877190/
https://www.ncbi.nlm.nih.gov/pubmed/33568152
http://dx.doi.org/10.1186/s13018-021-02251-6
work_keys_str_mv AT dongconglei doseatrophyofvastusmedialisobliquusandvastuslateralisexistinpatientswithpatellofemoralpainsyndrome
AT liming doseatrophyofvastusmedialisobliquusandvastuslateralisexistinpatientswithpatellofemoralpainsyndrome
AT haokuo doseatrophyofvastusmedialisobliquusandvastuslateralisexistinpatientswithpatellofemoralpainsyndrome
AT zhaochao doseatrophyofvastusmedialisobliquusandvastuslateralisexistinpatientswithpatellofemoralpainsyndrome
AT piaokang doseatrophyofvastusmedialisobliquusandvastuslateralisexistinpatientswithpatellofemoralpainsyndrome
AT linwei doseatrophyofvastusmedialisobliquusandvastuslateralisexistinpatientswithpatellofemoralpainsyndrome
AT fanchongyi doseatrophyofvastusmedialisobliquusandvastuslateralisexistinpatientswithpatellofemoralpainsyndrome
AT niuyingzhen doseatrophyofvastusmedialisobliquusandvastuslateralisexistinpatientswithpatellofemoralpainsyndrome
AT feiwang doseatrophyofvastusmedialisobliquusandvastuslateralisexistinpatientswithpatellofemoralpainsyndrome